MFRCX
Price
$49.49
Change
+$0.58 (+1.19%)
Updated
Jun 24 closing price
Net Assets
7.87B
VTSAX
Price
$145.88
Change
+$1.66 (+1.15%)
Updated
Jun 24 closing price
Net Assets
1.82T
Interact to see
Advertisement

MFRCX vs VTSAX

Header iconMFRCX vs VTSAX Comparison
Open Charts MFRCX vs VTSAXBanner chart's image
MFS Research C
Price$49.49
Change+$0.58 (+1.19%)
VolumeN/A
Net Assets7.87B
Vanguard Total Stock Mkt Idx Adm
Price$145.88
Change+$1.66 (+1.15%)
VolumeN/A
Net Assets1.82T
MFRCX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MFRCX vs. VTSAX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRCX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.82T vs. MFRCX (7.87B). VTSAX pays higher dividends than MFRCX: VTSAX (1.28) vs MFRCX (0.00). MFRCX was incepted earlier than VTSAX: MFRCX (31 years) vs VTSAX (25 years). MFRCX (1.52) is less costly to investors than VTSAX (0.04). MFRCX is a more actively managed with annual turnover of: 20.00 vs. VTSAX (2.00). MFRCX has a lower initial minimum investment than VTSAX: MFRCX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 10.75 vs. MFRCX (-3.64). VTSAX return over 5 years is better than : 91.07 vs. MFRCX (23.26).
MFRCXVTSAXMFRCX / VTSAX
Total Expense Ratio1.520.043,800%
Annual Report Gross Expense Ratio1.520.043,800%
Fund Existence31 years25 years-
Gain YTD1.3262.29458%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets7.87B1.82T0%
Annual Yield % from dividends0.001.28-
Returns for 1 year-3.6410.75-34%
Returns for 3 years11.9052.2823%
Returns for 5 years23.2691.0726%
Returns for 10 years34.09182.5219%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLEFX36.160.37
+1.03%
American Funds American Balanced R5E
FSAEX12.83N/A
N/A
Fidelity Series All-Sector Equity
HCYIX18.00N/A
N/A
Hilton Tactical Income Instl
GGHSX37.71N/A
N/A
Invesco Health Care R6
GUSOX21.81N/A
N/A
GMO U.S. Opportunistic Value IV